NDSI
ABBV icon

Newman Dignan & Sheerar Inc’s AbbVie ABBV Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
4,147
-110
-3% -$23.7K 0.2% 85
2026
Q1 		$926K Sell
4,257
-23
-0.5% -$5.1K 0.19% 89
2025
Q4 		$978K Buy
4,280
+60
+1% +$13.7K 0.2% 88
2025
Q3 		$977K Buy
4,220
+180
+4% +$36.7K 0.21% 85
2025
Q2 		$750K Buy
4,040
+5
+0.1% +$929 0.17% 98
2025
Q1 		$845K Buy
4,035
+150
+4% +$29.2K 0.23% 85
2024
Q4 		$690K Sell
3,885
-45
-1% -$8.27K 0.18% 99
2024
Q3 		$745K Buy
3,930
+20
+0.5% +$3.73K 0.18% 98
2024
Q2 		$671K Sell
3,910
-20
-0.5% -$3.31K 0.17% 104
2024
Q1 		$716K Sell
3,930
-39
-1% -$6.72K 0.19% 100
2023
Q4 		$615K Buy
+3,969
New +$579K 0.19% 103
2023
Q3 		– Sell
-4,020
Closed -$542K – 165
2023
Q2 		$542K Sell
4,020
-270
-6% -$39.6K 0.17% 111
2023
Q1 		$684K Sell
4,290
-50
-1% -$7.64K 0.22% 96
2022
Q4 		$701K Buy
4,340
+39
+0.9% +$5.98K 0.23% 96
2022
Q3 		$577 Buy
4,301
+89
+2% +$12.8K 0.09% 100
2022
Q2 		$645K Sell
4,212
-50
-1% -$7.64K 0.22% 100
2022
Q1 		$691 Buy
4,262
+375
+10% +$54.5K 0.13% 100
2021
Q4 		$526K Sell
3,887
-20
-0.5% -$2.36K 0.16% 110
2021
Q3 		$421K Hold
3,907
– – 0.12% 116
2021
Q2 		$440K Sell
3,907
-30
-0.8% -$3.38K 0.15% 116
2021
Q1 		$426K Hold
3,937
– – 0.15% 114
2020
Q4 		$422 Sell
3,937
-300
-7% -$28.8K 0.07% 108
2020
Q3 		$371K Buy
4,237
+606
+17% +$57.1K 0.16% 109
2020
Q2 		$349K Buy
3,631
+480
+15% +$42.3K 0.15% 108
2020
Q1 		$258K Sell
3,151
-405
-11% -$34.5K 0.14% 123
2019
Q4 		$315 Hold
3,556
– – 0.03% 128
2019
Q3 		$269K Sell
3,556
-100
-3% -$6.86K 0.13% 132
2019
Q2 		$266 Hold
3,656
– – 0.01% 148
2019
Q1 		$295K Sell
3,656
-390
-10% -$31.9K 0.12% 126
2018
Q4 		$373 Hold
4,046
– – 0.03% 107
2018
Q3 		$382K Buy
4,046
+73
+2% +$6.92K 0.17% 115
2018
Q2 		$368 Hold
3,973
– – 0.02% 115
2018
Q1 		$365K Buy
3,973
+343
+9% +$37.7K 0.18% 117
2017
Q4 		$351K Sell
3,630
-375
-9% -$35.3K 0.18% 122
2017
Q3 		$356K Sell
4,005
-200
-5% -$15.2K 0.19% 116
2017
Q2 		$305K Hold
4,205
– – 0.17% 121
2017
Q1 		$274 Hold
4,205
– – 0.12% 127
2016
Q4 		$263K Buy
4,205
+325
+8% +$19.8K 0.16% 125
2016
Q3 		$245K Sell
3,880
-350
-8% -$22.7K 0.15% 133
2016
Q2 		$262K Buy
4,230
+348
+9% +$21.2K 0.16% 129
2016
Q1 		$222K Buy
3,882
+408
+12% +$22.7K 0.16% 127
2015
Q4 		$206K Buy
+3,474
New +$200K 0.15% 138
2015
Q3 		– Sell
-3,447
Closed -$232K – 135
2015
Q2 		$232K Buy
+3,447
New +$225K 0.17% 135

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Newman Dignan & Sheerar Inc's ABBV Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $23.7K and leaving 4,147 shares worth $1.04M. The position accounts for 0.2% of the portfolio, ranked #85.

Newman Dignan & Sheerar Inc first reported a position in ABBV in Q2 2015 and has held it in 43 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 4,147 shares of AbbVie worth $1.04M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 110 AbbVie shares in Q2 2026, an estimated $23.7K.
  • AbbVie made up 0.2% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #85 holding.
  • Newman Dignan & Sheerar Inc first reported a position in AbbVie in Q2 2015 and has held it in 43 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.